Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Testicular tumors--a breakthrough?].

C G Schmidt

    Schweizerische Medizinische Wochenschrift
    |September 10, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Advances in chemotherapy have greatly improved testicular cancer survival. Prognosis in nonseminomatous germ cell tumors depends on human chorionic gonadotropin (HCG) levels and tumor burden, especially in disseminated stages.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Anti-depressants and anti-convulsants for the treatment of neuropathic pain syndromes in cancer patients.

    Onkologie·1991
    Same author

    Etoposide in patients with previously untreated non-small-cell lung cancer: a phase I study.

    Cancer chemotherapy and pharmacology·1991
    Same author

    Etoposide, ifosfamide, and methotrexate with or without bleomycin in refractory or recurrent lymphomas.

    Annals of oncology : official journal of the European Society for Medical Oncology·1991
    Same author

    Ifosfamide, methotrexate and 5-fluorouracil for pretreated advanced breast cancer.

    Oncology·1991
    Same author

    Interferon alfa-2b in acute- and chronic-phase chronic myelogenous leukaemia: initial response and long-term results in 54 patients.

    European journal of cancer (Oxford, England : 1990)·1991
    Same author

    [Burkitt's lymphoma in HIV-infected patients].

    Deutsche medizinische Wochenschrift (1946)·1990

    Area of Science:

    • Oncology
    • Medical Chemotherapy

    Context:

    • Nonseminomatous germ cell tumors (NSGCT) are a significant cause of cancer in young men.
    • Treatment advancements have led to improved outcomes over the past two decades.

    Purpose:

    • To present general trends and long-term experience with sequential combination chemotherapy for testicular cancer.
    • To analyze the relationship between survival rates, human chorionic gonadotropin (HCG) levels, and tumor burden in disseminated NSGCT.

    Summary:

    • Sequential combination chemotherapy regimens (velbane/bleomycin; adriamycin/cisplatin; ifosfamide/etoposide) were evaluated in testicular cancer patients.
    • Survival in disseminated stages was strongly correlated with initial HCG concentration and tumor burden.
    • Two-year survival rates varied significantly based on disease extent: >80% for minimal pulmonary disease, 40-50% for massive pulmonary disease, and <30% for pulmonary metastases with massive retroperitoneal disease.

    Related Experiment Videos

    Impact:

    • Highlights the critical role of baseline HCG and tumor burden in predicting NSGCT outcomes.
    • Underscores the effectiveness of multi-agent chemotherapy in improving survival for testicular cancer.
    • Suggests the need for novel diagnostic and therapeutic strategies to further enhance survival rates in advanced NSGCT.